Therapeutic Lateral Neck Dissection in Papillary Thyroid Carcinoma
Ali Zedan1, Waleed Ahmed Diab, Hemat A. Mahmoud, Haisam Atta
Ahead of print,
Article DOI: 10.21614/sgo-25-5-310
Objective: Papillary thyroid carcinoma (PTC) has a high rate of lateral neck node metastases, lymph node metastasis (LNM) is a vital prognosis factor. The aim of this study was to evaluate morbidity and outcomes of therapeutic lateral neck dissection papillary thyroid cancer (PTC) with lateral lymph node metastasis (LLNM).

Methods: We conducted a retrospective analysis of 78 PTC patients who underwent neck dissections for the management of lateral cervical metastases from January 2010 and January 2020.

Results: 35.9% and 16.7% presented multifocality and bilaterality, respectively. HashimotoĆ¢??s thyroiditis (16.7%), capsular invasion (23.1%), (12.8%) lymphovascular invasion, Extrathyroidal extension (19.2%). PTCs were distributed (38.5%) upper portion, (23.1%) middle portion, (38.5%) lower portion. Skip metastasis (10.3%), pT1 26%, pT2 42.5%, pT24.7% and pT4a 6.8%, tumor size 2.59+-1.16 cm, (48.7%) stage I, (41%) stage II, (10.3%) stage III, metastasis in levels I, II, III, IV and V was 14.1%, 48.7%, 62.8%, 57.7% and 19.2% (15 78), (20.5%) had single-level metastases, and (52.6%) had multiple-level metastases. Ipsilateral metastases in (80.8%) and bilateral metastases in 19.2%. Retrieved LNs was 32 (range, 18 62). Metastatic LNs 4 (range, 1 9) LNR was 0.14 +-0.08, shoulder dysfunction (7.8%), chyle leakage (9%), nodal recurrence (7.4%), 10-year RFS&OS survival rate 92.2%, (97.1%).

Conclusion: Therapeutic lateral neck dissection (LND) is recommended in PTC patients with clinically LLNM, at the time of thyroidectomy. locoregional control is improved with accepted morbidity.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 956


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2023

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/